SLU-PP-332 (250mcg x 60 Capsules = 15,000mcg)
SLU-PP-332 is an experimental compound designed to mimic the metabolic effects of exercise by activating estrogen-related receptors (ERRs), particularly ERRα, ERRβ, and ERRγ. This activation leads to increased energy expenditure, enhanced fatty acid oxidation, and improved mitochondrial function.
$110.00
SLU-PP-332: Overview
Everyone knows that repetitive physical exercise leads to improved health and wellness. Research has repeatedly revealed that exercise can thwart heart disease, fight obesity, improve mood, boost cognitive function, and even help to prevent/treat a number of diseases. For the most part, attempts to replicate the benefits of exercise using pharmaceuticals has fallen short. Even weight loss drugs were a bust until the recent advent of peptides like semaglutide and liraglutide. A new breakthrough is underway, however, and researchers have developed a compound that can replicate some of the benefits of exercise. SLU-PP-332 is an estrogen-related receptor (ERR) agonist that binds primarily to ERR subclasses alpha and gamma. It has been shown to improve skeletal muscle endurance, boost weight loss, improve cardiovascular health, and protect the central nervous system against the ravages of aging and disease. SLU-PP-332 is the closest science has yet come to replicating the effects of exercise and has, predictably, generated a great deal of interest in research circles.
Published Research:
-
Metabolic Benefits in Obese Mice: A study published in the Journal of Pharmacology and Experimental Therapeutics demonstrated that SLU-PP-332 administration in diet-induced obese or genetically obese (ob/ob) mice resulted in increased energy expenditure and fatty acid oxidation. These metabolic changes were accompanied by decreased fat mass accumulation, suggesting potential therapeutic applications for metabolic disorders. SLU-PP-332 has been shown to promote weight loss and reduce fat accumulation in obese mice without affecting food intake or requiring increased physical activity.
-
Enhanced Exercise Endurance: Research reported in ACS Chemical Biology found that SLU-PP-332 increased the proportion of oxidative muscle fibers in mice, leading to enhanced exercise endurance. This effect was attributed to improved mitochondrial function and cellular respiration in skeletal muscle cells.
-
Potential Treatment for Heart Failure: Studies presented by the American Chemical Society indicated that SLU-PP-332 improved cardiac function in mouse models of heart failure. The compound enhanced mitochondrial ultrastructure and upregulated pathways associated with oxidative phosphorylation and fatty acid metabolism, suggesting its potential as a therapeutic agent for heart failure.
American Chemical Society While these findings are promising, it’s important to note that SLU-PP-332 is still in the preclinical stage of development. Further research, including human clinical trials, is necessary to fully understand its efficacy and safety profile.
SLU-PP-332: Structure
Reviews